These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 23248080)

  • 1. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration.
    Huedo-Medina TB; Kirsch I; Middlemass J; Klonizakis M; Siriwardena AN
    BMJ; 2012 Dec; 345():e8343. PubMed ID: 23248080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
    Erman MK; Zammit G; Rubens R; Schaefer K; Wessel T; Amato D; Caron J; Walsh JK
    J Clin Sleep Med; 2008 Jun; 4(3):229-34. PubMed ID: 18595435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
    Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
    J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized placebo-controlled polysomnographic study of eszopiclone in Japanese patients with primary insomnia.
    Uchimura N; Kamijo A; Kuwahara H; Uchiyama M; Shimizu T; Chiba S; Inoue Y
    Sleep Med; 2012 Dec; 13(10):1247-53. PubMed ID: 23063301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [How well do Z-substances help in insomnia?].
    Baier PC
    MMW Fortschr Med; 2013 Jun; 155(12):30. PubMed ID: 23923306
    [No Abstract]   [Full Text] [Related]  

  • 6. Greater incidence of depression with hypnotic use than with placebo.
    Kripke DF
    BMC Psychiatry; 2007 Aug; 7():42. PubMed ID: 17711589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial.
    Rosenberg R; Murphy P; Zammit G; Mayleben D; Kumar D; Dhadda S; Filippov G; LoPresti A; Moline M
    JAMA Netw Open; 2019 Dec; 2(12):e1918254. PubMed ID: 31880796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis.
    Dündar Y; Dodd S; Strobl J; Boland A; Dickson R; Walley T
    Hum Psychopharmacol; 2004 Jul; 19(5):305-22. PubMed ID: 15252823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possibility that certain hypnotics might cause cancer in skin.
    Kripke DF
    J Sleep Res; 2008 Sep; 17(3):245-50. PubMed ID: 18844818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of eszopiclone: clinical and therapeutic implications.
    Greenblatt DJ; Zammit GK
    Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1609-18. PubMed ID: 23126273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
    Elie R; Rüther E; Farr I; Emilien G; Salinas E
    J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polysomnography study of eszopiclone in elderly patients with insomnia.
    McCall WV; Erman M; Krystal AD; Rosenberg R; Scharf M; Zammit GK; Wessel T
    Curr Med Res Opin; 2006 Sep; 22(9):1633-42. PubMed ID: 16968566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of treatment of insomnia in migraineurs with eszopiclone (Lunesta®) and its effect on total sleep time, headache frequency, and daytime functioning: A randomized, double-blind, placebo-controlled, parallel-group, pilot study.
    Spierings EL; McAllister PJ; Bilchik TR
    Cranio; 2015 Apr; 33(2):115-21. PubMed ID: 25323219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T; Soubrane C; Titeux L; Walsh JK;
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group.
    Hedner J; Yaeche R; Emilien G; Farr I; Salinas E
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):704-12. PubMed ID: 10960882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eszopiclone for insomnia associated with attention-deficit/hyperactivity disorder.
    Sangal RB; Blumer JL; Lankford DA; Grinnell TA; Huang H
    Pediatrics; 2014 Oct; 134(4):e1095-103. PubMed ID: 25266438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation.
    Dündar Y; Boland A; Strobl J; Dodd S; Haycox A; Bagust A; Bogg J; Dickson R; Walley T
    Health Technol Assess; 2004 Jun; 8(24):iii-x, 1-125. PubMed ID: 15193209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
    Krystal AD; Walsh JK; Laska E; Caron J; Amato DA; Wessel TC; Roth T
    Sleep; 2003 Nov; 26(7):793-9. PubMed ID: 14655910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia.
    Huang YS; Hsu SC; Liu SI; Chen CK
    Chang Gung Med J; 2011; 34(1):50-6. PubMed ID: 21392474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.